The following is a message e-mailed to financial advisors of stockholders of Carter Validus Mission Critical REIT, Inc. on July 22, 2019.
CARTER VALIDUS
MISSION CRITICAL REIT
Carter Validus Mission Critical REIT, Inc. & Carter Validus Mission Critical REIT II, Inc. Merger Update
Proxy Materials to Stockholders
NOTE: This is an update for financial advisors with existing investors only, as Carter Validus Mission Critical REIT, Inc. is closed to new subscribers.
As you may know, Carter Validus Mission Critical REIT, Inc. (“CVREIT”) entered into a definitive merger agreement with Carter Validus Mission Critical REIT II, Inc. (“CVREIT II”) to merge in a stock and cash transaction, which if consummated, would result in a combined company with an approximate enterprise value of $3.2 billion.
This week, proxy materials are being mailed to stockholders of record as of July 11, 2019, of CVREIT. As outlined in the proxy filing, if the merger closes, CVREIT stockholders will receive $1.00 per share in cash for each share of CVREIT owned as well as 0.4681 shares of CVREIT II Class A Common Stock for each share of CVREIT owned.
The boards of directors of both companies support the merger transaction and the management teams believe it is in the best interest of both CVREIT and CVREIT II stockholders. A press release was issued this morning providing an update on the merger process and announcing the availability of an animated video and a webcast discussion with the CEO to help address questions your clients may have.
Please encourage your clients to submit their vote as soon as possible by logging onto www.proxypush.com/cvreit, by calling toll free at 1-844-371-1437 to speak with a live representative or by mailing in the proxy card. If approved, and all other conditions are met, the merger is expected to be completed during the second half of 2019.
LINKS
Proxy Statement/Prospectus
CVREIT and CVREIT II Joint Press Release Guide to CVREIT Merger Video Merger Q&A with the CEO
If you have any questions, please contact the SC Distributors Sales Desk at
877-907-1148
No Offer or Solicitation
This communication shall not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.
Important Additional Information
In connection with the proposed transaction, CVREIT II has filed a Registration Statement on Form S-4 (File No. 333-232275), which has been declared effective by the U.S. Securities and Exchange Commission (the “SEC”), and which contains a proxy statement of CVREIT and also constitutes a prospectus of CVREIT II. This proxy statement/prospectus has been mailed to CVREIT’s stockholders. WE URGE INVESTORS TO READ THE PROXY STATEMENT/PROSPECTUS AND ANY OTHER RELEVANT DOCUMENTS FILED BY CVREIT AND CVREIT II IN CONNECTION WITH THE PROPOSED MERGER WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT CVREIT, CVREIT II AND THE PROPOSED MERGER. INVESTORS ARE URGED TO READ THESE DOCUMENTS CAREFULLY AND IN THEIR ENTIRETY. Investors may obtain these materials and other documents filed with the SEC free of charge at the SEC’s website (www.sec.gov). In addition, these materials also are available free of charge by accessing CVREIT’s website (www.cvmissioncriticalreit.com) or by accessing CVREIT II’s website (www.cvmissioncriticalreit2.com).
Forward-Looking Statements
This communication contains statements that constitute “forward-looking statements,” as such term is defined in Section